More serious issues than the name change, page-12

Yes excellent judgment jamwolf obviously the guys smarter than us .
Everybody wants a deal ! We've had countless deals that go nowhere .
The real problem is in the lab . This mob cant publish , cant present at pain conferences and cant entice big pharma . There off the pain industry radar . And KC a direct ' look what we've got for you' approach wont work
Forget deals this coy needs the expertise , funding and energy of a large pharmaceutical partner .
If your waiting for further excellent trial results from Alyptus your going to be very disappointed in the response .
I've spoken to more pharma execs than poh in recent years . Their attitude is always , little bios get it wrong , why should we referee their work , they can waste your time and money . Throw in the poh reputation and your Buckleys .
Time for a new business plan based on scientific credibility .